NCT07398846CompletedPhase 3
Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
A 12-Week Clinical Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
To evaluate the efficacy of a stannous fluoride toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
- Status (registry)
- Completed
- Phase (registry)
- Phase 3
- Study type
- Interventional
- Enrollment
- 134 (actual)
- First submitted
- 27 Jan 2026
- Start date
- 26 Jan 2026
- Primary completion date
- 29 Apr 2026
- Lead sponsor
- Colgate Palmolive
- NCT number
- NCT07398846
What you commit to
- Study type: Interventional · Phase 3
- Participants enrolled: 134
- From 26 Jan 2026 to the primary completion date, 29 Apr 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of anticonvulsants, sedatives, tranquilizers, anti-inflammatory or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study;
- Use of antibiotics any time during the one-month period prior to entry into the study;
- Dental prophylaxis within the past three weeks prior to baseline examinations;
Other illness
- Oral pathology, chronic disease or tumor(s) of the soft or hard tissues of the oral cavity; 4. Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone);
- Current allergies and/or history of allergic reactions to oral care products, personal care consumer products, or any of their ingredients;
- An existing medical condition that prohibits eating and/or drinking for periods up to 4 hours;
- Current smokers and/or a history of alcohol or drug abuse
Lab values
- Ongoing use of medications known to affect the gingival tissues (i.e. calcium channel blockers, phenytoin, cyclosporine) and/or on any prescription medicines that might interfere with the study outcome;
Other
- Presence of orthodontic appliances;
- Presence of partial removable dentures;
- Five or more carious lesions requiring immediate restorative treatment;
- Participation in any other clinical study;
- Self-reported pregnancy and/or breastfeeding;
Who the study is looking for
- Signed Informed Consent Form.
- Male and female subjects aged 18-70 years, inclusive.
- Availability for the twelve-week duration of the clinical research study.
- Good general health based on the opinion of the study investigator
- Minimum of 20 permanent natural teeth (excluding third molars).
- Initial gingivitis index of at least 1.0 as determined by the use of the Loe and Silness Gingival Index.
- Initial mean plaque index of at least 0.6 as determined by Rustogi Modification of the Navy plaque index.
Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Consumer Research Consulting, LLC Coordinator of this site? Confirm its status | Melbourne | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.